Novactyl, Inc.
Records under this name other than patents Novactyl, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 10 of 10 · Back to Novactyl, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,127,393 | Antiproliferative, antiinfective, antiinflammatory, autologous immunization agent and method Formerly held Term ended Term ended Aug 1, 2018 · From the USPTO record | Term ended | Term ended Aug 1, 2018 | From the USPTO record |
| US 6,410,570 | Methods of inactivating a virus and controlling viral replication Formerly held Lapsed on the fee record Ended Jun 25, 2014 · From the USPTO record | Lapsed on the fee record | Ended Jun 25, 2014 | From the USPTO record |
| US 6,407,125 | Pharmacological agent and method of treatment Formerly held Lapsed on the fee record Ended Jun 18, 2014 · From the USPTO record | Lapsed on the fee record | Ended Jun 18, 2014 | From the USPTO record |
| US 6,743,771 | Methods and compositions for controlling protein assembly or aggregation Formerly held Lapsed on the fee record Ended Jun 1, 2012 · From the USPTO record | Lapsed on the fee record | Ended Jun 1, 2012 | From the USPTO record |
| US 6,939,884 | Pharmaceutical agents containing acyclovir, fusaric acid and derivatives thereof Lapsed on the fee record Ended Sep 6, 2009 · From the USPTO record | Lapsed on the fee record | Ended Sep 6, 2009 | From the USPTO record |
| US 6,579,891 | Agent and method for prevention and treatment of cancer in animals Lapsed on the fee record Ended Jun 17, 2007 · From the USPTO record | Lapsed on the fee record | Ended Jun 17, 2007 | From the USPTO record |
| US 6,569,864 | Pharmaceutical agents containing acyclovir, fusaric acid and derivatives thereof Lapsed on the fee record Ended May 27, 2007 · From the USPTO record | Lapsed on the fee record | Ended May 27, 2007 | From the USPTO record |
| US 6,441,009 | Agent and method of preventing and treating heavy metal exposure and toxicity Formerly held Lapsed on the fee record Ended Aug 27, 2006 · From the USPTO record | Lapsed on the fee record | Ended Aug 27, 2006 | From the USPTO record |
| US 6,403,618 | Agent and method for controlling angiogenesis Lapsed on the fee record Ended Jun 11, 2006 · From the USPTO record | Lapsed on the fee record | Ended Jun 11, 2006 | From the USPTO record |
| US 5,767,135 | Antiviral agent Formerly held Term ended Term ended no later than Jun 16, 2018 · Low confidence | Term ended | Term ended no later than Jun 16, 2018 | Low confidence |